I've been following this company for more than 20 years, since the earliest days of biotech.
It's a company that has helped revolutionize MS treatment. And it is now focusing its attention on another insidious and even more pervasive disease: Alzheimer's.
The company also has a number of well-regarded drugs in the marketplace that have helped patients with B-cell non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, and hemophilia.
Plain and simple, it's a company that has success built into its DNA.That's why this stock has soared and will continue to soar as the years roll on...